| 1 |
2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al. · Journal of the American College of Cardiology
Open access |
5 Jun 2013 |
12,642 |
| 2 |
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Aimun Ahmed, Tom Jorna, Sunil Bhandari · The Nephron journals/Nephron journals
|
2016 |
11,736 |
| 3 |
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al. · European Heart Journal
Open access134 authors |
20 May 2016 |
11,598 |
| 4 |
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt, Faiez M. Zannad, Willem J. Remme et al. · New England Journal of Medicine
Open access |
2 Sep 1999 |
9,197 |
| 5 |
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
The Heart Outcomes Prevention Evaluation Study Investigators · New England Journal of Medicine
Open access |
20 Jan 2000 |
8,696 |
| 6 |
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine
Open access |
13 Jun 2016 |
7,629 |
| 7 |
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay Suvas Desai et al. · New England Journal of Medicine
Open access |
30 Aug 2014 |
6,982 |
| 8 |
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors Task Force Members et al. · European Heart Journal
|
18 May 2012 |
6,931 |
| 9 |
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Marc Alan Pfeffer, Eugene Braunwald, Lemuel A. Moyé et al. · New England Journal of Medicine
|
3 Sep 1992 |
5,965 |
| 10 |
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Piotr P. Ponikowski et al. · European Journal of Heart Failure
Open access |
20 May 2016 |
5,934 |
| 11 |
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
Stephen F. Jencks, Mark V. Williams, Eric A. Coleman · New England Journal of Medicine
|
Apr 2009 |
5,226 |
| 12 |
Measurement of health status
Roman Jaeschke, Joel Singer, Gordon Henry Guyatt · Controlled Clinical Trials
|
Dec 1989 |
4,989 |
| 13 |
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Bertram Pitt, Willem J. Remme, Faiez M. Zannad et al. · New England Journal of Medicine
Open access |
2 Apr 2003 |
4,965 |
| 14 |
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Milton Packer, Michael R. Bristow, Jay N. Cohn et al. · New England Journal of Medicine
Open access |
23 May 1996 |
4,686 |
| 15 |
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Theophilus Owan, David O. Hodge, Regina M. Herges et al. · New England Journal of Medicine
|
19 Jul 2006 |
4,233 |
| 16 |
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert et al. · European Heart Journal
Open access |
26 Aug 2022 |
3,956 |
| 17 |
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galiè et al. · European Heart Journal
Open access |
27 Aug 2009 |
3,873 |
| 18 |
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Sharon A. Hunt, William T. Abraham, Marshall H. Chin et al. · Circulation
|
27 Mar 2009 |
3,724 |
| 19 |
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Walter J. Paulus, Carsten Tschöpe · Journal of the American College of Cardiology
Open access |
15 May 2013 |
3,567 |
| 20 |
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
The ONTARGET Investigators · New England Journal of Medicine
Open access |
31 Mar 2008 |
3,538 |
| 21 |
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Alan S. Maisel, Padma Krishnaswamy, Richard M. Nowak et al. · New England Journal of Medicine
|
18 Jul 2002 |
3,385 |
| 22 |
Global burden of heart failure: a comprehensive and updated review of epidemiology
Gianluigi Savarese, Peter Moritz Becher, Lars H. Lund et al. · Cardiovascular Research
|
8 Feb 2022 |
3,321 |
| 23 |
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Clyde W. Yancy et al. · Circulation
|
6 Jun 2013 |
3,321 |
| 24 |
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galiè et al. · European Respiratory Journal
Open access |
29 Aug 2015 |
3,202 |
| 25 |
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Arthur J. Moss, William Jackson Hall, David S. Cannom et al. · New England Journal of Medicine
|
Sep 2009 |
3,177 |
| 26 |
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy, Mariell L Jessup, Biykem Bozkurt et al. · Circulation
Open access |
28 Apr 2017 |
3,176 |
| 27 |
A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
A.J. de Bold, Heidi Borenstein, Anthony T. Veress et al. · Life Sciences
|
1981 |
3,166 |
| 28 |
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Jay N. Cohn, T. Barry Levine, Maria Teresa Olivari et al. · New England Journal of Medicine
|
27 Sep 1984 |
3,142 |
| 29 |
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Jay N. Cohn, Gianni Tognoni · New England Journal of Medicine
Open access |
6 Dec 2001 |
3,116 |
| 30 |
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Faiez M. Zannad, John J.V. McMurray, Henry Krum et al. · New England Journal of Medicine
Open access |
14 Nov 2010 |
3,112 |
| 31 |
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
Milton Packer, Andrew J.S. Coats, Michael B. Fowler et al. · New England Journal of Medicine
Open access |
31 May 2001 |
3,110 |
| 32 |
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
The Digitalis Investigation Group · New England Journal of Medicine
Open access |
20 Feb 1997 |
3,043 |
| 33 |
Obesity and the Risk of Heart Failure
Satish Kenchaiah, Jane Cooper Evans, Daniel Levy et al. · New England Journal of Medicine
|
Aug 2002 |
3,043 |
| 34 |
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Salim Yusuf, Marc Alan Pfeffer, Karl B Swedberg et al. · The Lancet
|
Sep 2003 |
3,011 |
| 35 |
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Margaret M. Redfield, Steven J. Jacobsen, John C. Jr Burnett et al. · JAMA
|
8 Jan 2003 |
3,010 |
| 36 |
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf, Peter Sever, Neil R Poulter et al. · The Lancet
|
Sep 2005 |
2,928 |
| 37 |
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz et al. · The Lancet
Review |
10 Nov 2018 |
2,882 |
| 38 |
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott David Solomon et al. · New England Journal of Medicine
Open access |
27 Aug 2022 |
2,863 |
| 39 |
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
Jay N. Cohn, Gary R. Johnson, Susan Ziesche et al. · New England Journal of Medicine
Open access |
Aug 1991 |
2,854 |
| 40 |
Forecasting the Impact of Heart Failure in the United States
Paul A. Heidenreich, Nancy M. Albert, Larry A. Allen et al. · Circulation Heart Failure
Open access |
24 Apr 2013 |
2,833 |
| 41 |
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
Marlies Antlanger, Stefan Aschauer, Chantal Kopecky et al. · Kidney & Blood Pressure Research
Open access |
2017 |
2,819 |
| 42 |
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al. · New England Journal of Medicine
Open access |
9 Apr 2014 |
2,808 |
| 43 |
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
Serge Cazeau, Christophe Leclercq, Thomas Lavergne et al. · New England Journal of Medicine
Open access |
22 Mar 2001 |
2,768 |
| 44 |
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Authors Task Force Members et al. · European Heart Journal
|
17 Sep 2008 |
2,707 |
| 45 |
Global Public Health Burden of Heart Failure
Gianluigi Savarese, Lars H. Lund · Cardiac failure review
Open access |
2017 |
2,700 |
| 46 |
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus, Carsten Tschöpe, John Elsby Sanderson et al. · European Heart Journal
|
11 Apr 2007 |
2,687 |
| 47 |
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, Mary Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine
Open access |
8 Jun 2015 |
2,619 |
| 48 |
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
John J.V. McMurray, Jan Östergren, Karl B Swedberg et al. · The Lancet
|
Sep 2003 |
2,612 |
| 49 |
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
Jay N. Cohn, Roberto Ferrari, Norman Sharpe · Journal of the American College of Cardiology
Open access |
Mar 2000 |
2,603 |
| 50 |
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
José Luis Zamorano et al. · European Heart Journal
Open access |
24 Aug 2016 |
2,586 |